Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lane J Brunner

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
American Journal of Pharmaceutical Education|May 30, 2013
Team-based learning in pharmacy educationWilliam Ofstad, Lane J Brunner
PDA Journal of Pharmaceutical Science and Technology|February 10, 2004
The effect of lipoprotein-associated cyclosporine on drug metabolism and toxicity in ratsTaekrho Kim, Shirley K Lu, Lane J Brunner
Drug Development and Industrial Pharmacy|August 9, 2003
Effect of sodium alterations on hepatic cytochrome P450 3A2 and 2C11 and renal function in ratsJinrong Liu, Shellie M Callahan, Lane J Brunner
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Suppression of hepatic CYP3A1/2 and CYP2C11 by cyclosporine is not mediated by altering growth hormone levelsShirley K Lu, Shellie M Callahan, Lane J Brunner
Alcoholism, Clinical and Experimental Research|April 20, 2002
Effect of gender and estrous cycle on the pharmacokinetics of ethanol in the rat brainDonita L Robinson, Lane J Brunner, Rueben A Gonzales
Aviation, Space, and Environmental Medicine|February 16, 2002
Altered cytochrome P450 and P-glycoprotein levels in rats during simulated weightlessnessShirley K Lu, Shuang Bai, Khalid Javeri, et al.
Transplantation|July 9, 2004
Metabolic interaction between cyclosporine and sirolimusShuang Bai, Stanislaw M Stepkowski, Barry D Kahan, et al.
European Journal of Pharmacology|October 7, 2004
Cyclosporine and bromocriptine-induced suppressions of CYP3A1/2 and CYP2C11 are not mediated by prolactinShirley K Lu, Shellie M Callahan, Runyan Jin, et al.
PDA Journal of Pharmaceutical Science and Technology|December 18, 2003
Effect of high-density lipoprotein associated cyclosporine on hepatic metabolism and renal functionTaekrho Kim, Shellie M Callahan, Kishor M Wasan, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2004
Considerations for use of recombinant adenoviral vectors: dose effect on hepatic cytochromes P450Shellie M Callahan, Xin Ming, Shirley K Lu, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
American Journal of Pharmaceutical Education|May 30, 2013
Team-based learning in pharmacy educationWilliam Ofstad, Lane J Brunner
PDA Journal of Pharmaceutical Science and Technology|February 10, 2004
The effect of lipoprotein-associated cyclosporine on drug metabolism and toxicity in ratsTaekrho Kim, Shirley K Lu, Lane J Brunner
Drug Development and Industrial Pharmacy|August 9, 2003
Effect of sodium alterations on hepatic cytochrome P450 3A2 and 2C11 and renal function in ratsJinrong Liu, Shellie M Callahan, Lane J Brunner
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Suppression of hepatic CYP3A1/2 and CYP2C11 by cyclosporine is not mediated by altering growth hormone levelsShirley K Lu, Shellie M Callahan, Lane J Brunner
Alcoholism, Clinical and Experimental Research|April 20, 2002
Effect of gender and estrous cycle on the pharmacokinetics of ethanol in the rat brainDonita L Robinson, Lane J Brunner, Rueben A Gonzales
Aviation, Space, and Environmental Medicine|February 16, 2002
Altered cytochrome P450 and P-glycoprotein levels in rats during simulated weightlessnessShirley K Lu, Shuang Bai, Khalid Javeri, et al.
Transplantation|July 9, 2004
Metabolic interaction between cyclosporine and sirolimusShuang Bai, Stanislaw M Stepkowski, Barry D Kahan, et al.
European Journal of Pharmacology|October 7, 2004
Cyclosporine and bromocriptine-induced suppressions of CYP3A1/2 and CYP2C11 are not mediated by prolactinShirley K Lu, Shellie M Callahan, Runyan Jin, et al.
PDA Journal of Pharmaceutical Science and Technology|December 18, 2003
Effect of high-density lipoprotein associated cyclosporine on hepatic metabolism and renal functionTaekrho Kim, Shellie M Callahan, Kishor M Wasan, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2004
Considerations for use of recombinant adenoviral vectors: dose effect on hepatic cytochromes P450Shellie M Callahan, Xin Ming, Shirley K Lu, et al.
Pageof 2